IP Library Granted Patent US 7,040,756
Granted Patent B2
US 7,040,756 · App. 10/409,926 · Granted May 9, 2006

Process for surface modifying substrates and modified substrates resulting therefrom

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,040,756
App. No.
10/409,926
Granted
May 9, 2006
Kind
B2
Abstract

The present invention generally relates to a method of modifying the surface of substrates such as contact lenses and other biomedical articles by at least partially coating the surfaces of such substrates with a polymeric tie layer having reactive sites. Various other moieties may then be chemically attached to the article surface by reaction of the other moieties with the reactive sites through classical chemical attachment mechanisms.

Claims (20)

1. A contact lens, comprising a bioactive coating on the surface of the contact lens, wherein the bioactive coating includes an organoselenium compound.

2. The contact lens of claim 1 , wherein the bioactive coating is covalently attached to the contact lens.

3. The contact lens of claim 2 , wherein the contact lens includes a polyelectrolytic tie layer on its surface, and wherein the bioactive coating is covalently attached to the contact lens.

4. The contact lens of claim 3 , wherein said polyelectrolytic tie layer is composed of (i) one layer of a first polyionic material which is not covalently attached to the surface of the article or (ii) at least one layer of the first polyionic material which is not covalently attached to the surface of the article and at least one layer of a second polyionic material having charges opposite of the charges of the first polyionic material, wherein said first and second polyionic materials have functional groups which provide reactive sites.

5. The contact lens of claim 2 , wherein the organoselenium compound is selenocystamine.

6. The contact lens of claim 3 , wherein the organoselenium compound is selenocystamine.

7. The contact lens of claim 4 , wherein the organoselenium compound is selenocystamine.

8. The contact lens of claim 2 , wherein the contact lens is a soft hydrogel contact lens.

9. The contact lens of claim 3 , wherein the contact lens is a soft hydrogel contact lens.

10. The contact lens of claim 1 , wherein the contact lens is capable of reducing the number of viable organisms comparing to a contact lens without the bioactive coating.

11. The contact lens of claim 10 , wherein the reduction in the number of viable organisms is at least one logarithm.

12. The contact lens of claim 10 , wherein the reduction in the number of viable organisms is at least two logarithms.

13. The contact lens of claim 10 , wherein the bioactive coating is covalently attached to the contact lens.

14. The contact lens of claim 13 , wherein the contact lens includes a polyelectrolytic tie layer on its surface, and wherein the bioactive coating is covalently attached to the contact lens.

15. The contact lens of claim 14 , wherein said polyelectrolytic tie layer is composed of (i) one layer of a first polyionic material which is not covalently attached to the surface of the article or (ii) at least one layer of the first polyionic material which is not covalently attached to the surface of the article and at least one layer of a second polyionic material having charges opposite of the charges of the first polyionic material, wherein said first and second polyionic materials have functional groups which provide reactive sites.

16. The contact lens of claim 13 , wherein the organoselenium compound is selenocystamine.

17. The contact lens of claim 14 , wherein the organoselenium compound is selenocystamine.

18. The contact lens of claim 15 , wherein the organoselenium compound is selenocystamine.

19. The contact lens of claim 10 , wherein the contact lens is a soft hydrogel contact lens.

20. The contact lens of claim 13 , wherein the contact lens is a soft hydrogel contact lens.

Assignments (3)
CONFIRMATORY DEED OF ASSIGNMENT EFFECTIVE APRIL 8, 2019 Recorded Dec 10, 2019
From: NOVARTIS AG
To: ALCON INC.
Reel/Frame 051454/0788 →
CORRECTIVE ASSIGNMENT TO REMOVE CONVEYING PARTY'S 4-7 DATA AND CORRECT SUPPORTING DOCUMENT PREVIOUSLY RECORDED ON REEL 033746 FRAME 0669. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Mar 30, 2017
From: QUIU, YONGXING; WINTERTON, LYNN COOK; LALLY, JOHN MARTIN
To: NOVARTIS AG
Reel/Frame 042114/0431 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 16, 2014
From: QIU, YONGXING; WINTERTON, LYNN COOK; LALLY, JOHN MARTIN; PASIC, PAUL; GRIESSER, HANS; KAMBOURIS, PETER; CHABRECEK, PETER
To: NOVARTIS AG
Reel/Frame 033746/0669 →